ES2185146T3 - Receptores de netrina. - Google Patents
Receptores de netrina.Info
- Publication number
- ES2185146T3 ES2185146T3 ES98906547T ES98906547T ES2185146T3 ES 2185146 T3 ES2185146 T3 ES 2185146T3 ES 98906547 T ES98906547 T ES 98906547T ES 98906547 T ES98906547 T ES 98906547T ES 2185146 T3 ES2185146 T3 ES 2185146T3
- Authority
- ES
- Spain
- Prior art keywords
- unc
- proteins
- vertebrate
- relates
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 101150032479 UNC-5 gene Proteins 0.000 abstract 4
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- JVJUWEFOGFCHKR-UHFFFAOYSA-N 2-(diethylamino)ethyl 1-(3,4-dimethylphenyl)cyclopentane-1-carboxylate;hydrochloride Chemical class Cl.C=1C=C(C)C(C)=CC=1C1(C(=O)OCCN(CC)CC)CCCC1 JVJUWEFOGFCHKR-UHFFFAOYSA-N 0.000 abstract 1
- 102000010803 Netrins Human genes 0.000 abstract 1
- 108010063605 Netrins Proteins 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 229960000074 biopharmaceutical Drugs 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000009134 cell regulation Effects 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 210000005260 human cell Anatomy 0.000 abstract 1
- 238000009396 hybridization Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 230000006798 recombination Effects 0.000 abstract 1
- 238000005215 recombination Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
- 230000009870 specific binding Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Abstract
La invención se refiere a procedimientos y a composiciones de proteínas UNC-5 de vertebrados, que funciona como proteínas receptoras de las netrinas, una familia de proteínas de regulación celular. Estas proteínas pueden ser producidas por recombinación a partir de células huésped transformadas a partir de dicha UNC-5 que codifica un ácido nucléico, o purificadas a partir de células humanas. La invención se refiere también a sondas y a cebos de hibridación, capaces de hibridarse específicamente con el gen unc-5 de vertebrados de la presente invención. La invención se refiere finalmente a agentes de enlace específicos de la UNC-5 de vertebrados como anticuerpos específicos, aí como a procedimientos de fabricación y de utilización de dichas composiciones en el diagnóstico, la terapia y la industria biofarmacéutica.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/808,982 US5939271A (en) | 1997-02-19 | 1997-02-19 | Netrin receptor |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2185146T3 true ES2185146T3 (es) | 2003-04-16 |
Family
ID=25200268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES98906547T Expired - Lifetime ES2185146T3 (es) | 1997-02-19 | 1998-02-19 | Receptores de netrina. |
Country Status (11)
Country | Link |
---|---|
US (6) | US5939271A (es) |
EP (1) | EP0973794B1 (es) |
JP (2) | JP2001505062A (es) |
AT (1) | ATE226216T1 (es) |
AU (1) | AU718795B2 (es) |
CA (1) | CA2280290C (es) |
DE (1) | DE69808743T2 (es) |
DK (1) | DK0973794T3 (es) |
ES (1) | ES2185146T3 (es) |
PT (1) | PT973794E (es) |
WO (1) | WO1998037085A1 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020137890A1 (en) * | 1997-03-31 | 2002-09-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US6350583B1 (en) * | 1997-09-09 | 2002-02-26 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the prostate |
ES2322859T3 (es) | 1998-05-01 | 2009-06-30 | Gen-Probe Incorporated | Analizador de diagnostico automatizado. |
WO2000053735A2 (en) * | 1999-03-10 | 2000-09-14 | Mcgill University | Methods for identifying modulators of synaptic plasticity and cell motility |
GB9912755D0 (en) * | 1999-06-01 | 1999-08-04 | Devgen Nv | UNC-5 constructs and screening methods |
US20030204052A1 (en) * | 2000-10-04 | 2003-10-30 | Herrmann John L. | Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
US6600018B1 (en) * | 2000-04-10 | 2003-07-29 | The United States Of America As Represented By The Department Of Health And Human Services | Secreted frizzled related protein, sFRP, fragments and methods of use thereof |
US6465632B1 (en) * | 2000-06-09 | 2002-10-15 | Lexicon Genetics Incorporated | Human phosphatases and polynucleotides encoding the same |
WO2001098354A2 (en) * | 2000-06-21 | 2001-12-27 | Incyte Genomics, Inc. | Human receptors |
WO2002010216A2 (en) * | 2000-07-28 | 2002-02-07 | Curagen Corporation | Proteins and nucleic acids encoding same |
AU2001293870A1 (en) * | 2000-10-16 | 2002-04-29 | Bayer Aktiengesellschaft | Regulation of human netrin binding membrane receptor unc5h-1 |
WO2002057450A2 (en) * | 2000-11-29 | 2002-07-25 | Curagen Corporation | Proteins and nucleic acids encoding same |
US7488710B2 (en) * | 2001-01-10 | 2009-02-10 | The United States Of America As Represented By The Department Of Health And Human Services | SFRP and peptide motifs that interact with SFRP and methods of their use |
US7109000B2 (en) | 2001-03-08 | 2006-09-19 | Curagen Corporation | Proteins and nucleic acids encoding same |
JP3746497B2 (ja) | 2003-06-24 | 2006-02-15 | 松下電器産業株式会社 | フォトマスク |
WO2005074556A2 (en) * | 2004-01-30 | 2005-08-18 | The General Hospital Corporation | Netrin compositions and methods of use thereof |
WO2006019904A1 (en) | 2004-07-14 | 2006-02-23 | University Of Utha Research Foundation | Netrin-related compositions and uses |
PL1989546T3 (pl) | 2006-02-28 | 2017-03-31 | Centre National De La Recherche Scientifique (Cnrs) | Poszukiwanie związków o działaniu przeciwnowotworowym z zastosowaniem aktywności netryny-1 |
AR074369A1 (es) * | 2008-11-20 | 2011-01-12 | Genentech Inc | Anticuerpos anti-unc 5b (receptor de netrina) y metodos de uso |
EP3584260A1 (en) | 2015-04-28 | 2019-12-25 | Mitsubishi Tanabe Pharma Corporation | Rgma binding protein and use thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3665893A (en) * | 1992-02-12 | 1993-09-03 | United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The | Sequences characteristic of human gene transcription product |
US5747262A (en) * | 1995-10-16 | 1998-05-05 | The Regents Of The University Of California | Neurological drug screens |
-
1997
- 1997-02-19 US US08/808,982 patent/US5939271A/en not_active Expired - Lifetime
-
1998
- 1998-02-19 DK DK98906547T patent/DK0973794T3/da active
- 1998-02-19 ES ES98906547T patent/ES2185146T3/es not_active Expired - Lifetime
- 1998-02-19 PT PT98906547T patent/PT973794E/pt unknown
- 1998-02-19 WO PCT/US1998/003143 patent/WO1998037085A1/en active IP Right Grant
- 1998-02-19 CA CA002280290A patent/CA2280290C/en not_active Expired - Lifetime
- 1998-02-19 AT AT98906547T patent/ATE226216T1/de active
- 1998-02-19 EP EP98906547A patent/EP0973794B1/en not_active Expired - Lifetime
- 1998-02-19 AU AU61744/98A patent/AU718795B2/en not_active Expired
- 1998-02-19 DE DE69808743T patent/DE69808743T2/de not_active Expired - Lifetime
- 1998-02-19 JP JP53684098A patent/JP2001505062A/ja active Pending
-
1999
- 1999-05-07 US US09/306,902 patent/US6277585B1/en not_active Expired - Lifetime
-
2001
- 2001-08-20 US US09/933,261 patent/US20030040046A1/en not_active Abandoned
-
2002
- 2002-09-27 US US10/256,702 patent/US7041806B2/en not_active Expired - Fee Related
-
2003
- 2003-09-11 JP JP2003319186A patent/JP4387735B2/ja not_active Expired - Lifetime
-
2006
- 2006-03-07 US US11/370,424 patent/US20060147988A1/en not_active Abandoned
-
2008
- 2008-05-01 US US12/151,062 patent/US7919588B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2001505062A (ja) | 2001-04-17 |
US20030040046A1 (en) | 2003-02-27 |
CA2280290A1 (en) | 1998-08-27 |
ATE226216T1 (de) | 2002-11-15 |
DE69808743T2 (de) | 2003-07-24 |
US20030059859A1 (en) | 2003-03-27 |
US6277585B1 (en) | 2001-08-21 |
DK0973794T3 (da) | 2002-11-11 |
JP4387735B2 (ja) | 2009-12-24 |
AU718795B2 (en) | 2000-04-20 |
EP0973794A1 (en) | 2000-01-26 |
WO1998037085A1 (en) | 1998-08-27 |
US20080241857A1 (en) | 2008-10-02 |
US7041806B2 (en) | 2006-05-09 |
AU6174498A (en) | 1998-09-09 |
US5939271A (en) | 1999-08-17 |
US7919588B2 (en) | 2011-04-05 |
JP2004121244A (ja) | 2004-04-22 |
EP0973794A4 (en) | 2000-12-06 |
PT973794E (pt) | 2003-03-31 |
US20060147988A1 (en) | 2006-07-06 |
DE69808743D1 (en) | 2002-11-21 |
CA2280290C (en) | 2003-10-07 |
EP0973794B1 (en) | 2002-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2185146T3 (es) | Receptores de netrina. | |
ATE418563T1 (de) | Nik proteine, nukleinsäure sowie verfahren | |
ATE237312T1 (de) | In liposomen verkapselte nukleinsäurekomplexe | |
WO2007002261A3 (en) | IL-1β BINDING ANTIBODIES AND FRAGMENTS THEREOF | |
EP1005540A4 (en) | IKK-BETA PROTEINS, NUCLEIC ACIDS AND METHODS | |
ES8802182A1 (es) | Un procedimiento para preparar una linfotoxina. | |
DK1337629T3 (da) | Dipeptidylpeptidaser | |
BRPI0516572A (pt) | métodos e composições para melhorar a produção de proteìnas recombinantes | |
CA2079454A1 (en) | Steroid 5.alpha.-reductases | |
WO2002006457A3 (en) | Novel lipase genes | |
ATE284383T1 (de) | Verbindungen, ihre herstellung und ihre verwendung für den transfer von nucleinsäuren in zellen | |
DE60043428D1 (de) | POLYPEPTIDE MIT VERZWEIGUNGSENZYM-AKTIVITäT UND FüR DIESE KODIERENDE NUKLEINSäUREN | |
DE3382789T2 (de) | Tierische Interferone, Verfahren bei deren Herstellung, dieselben enthaltende Zusammensetzungen, kodierende DNS-Sequenzen hierfür und diese Sequenzen enthaltende Expressionsvektoren und dadurch transformierte Zellen. | |
ATE279441T1 (de) | Verfahren zur herstellung von genetisch veränderten lymphozyten vorläuferzellen von wirbeltieren und deren gebrauch zur produktion von heterologen bindeproteinen | |
ATE513851T1 (de) | Menschliches gen zur fruchtbarkeit entscheidend | |
WO1995011919A3 (de) | REKOMBINANTE PilC-PROTEINE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG | |
WO2002090524A3 (en) | Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof | |
Pease et al. | Mapping class I gene sequences in the major histocompatibility complex | |
WO1998011232A3 (en) | Human nm23-like protein | |
DE602005019421D1 (de) | Grosstechnisch geeigneter mikroorganismus | |
AR013801A1 (es) | Nuevas moleculas de acido nucleico aislada, una proteina de epoxido hidrolasa de artropodo hematofago aislada, una formulacion de proteinas deepoxido hidrolasa de pulga, una composicion terapeutica que reduce la infestacion de ectoparasitos hematofagos; uso de dicha composicion para la | |
ATE399794T1 (de) | Modifizierter granulozyten stimulierender factor (g-csf) mit verringerter immunogenität | |
WO2000047723A3 (en) | Human diacylglycerol kinase beta (hdagk beta) proteins and nucleotide sequences encoding the same | |
MXPA02004825A (es) | Genes especificamente expresados en celulas dendriticas humanas. | |
EP1434483A4 (en) | NUCLEIC ACID CODING, LINKED CHROMO / FLUORESCENT DOMAINS AND METHOD OF USE THEREOF |